PHIA Koninklijke Philips N.V.

Philips first of its kind ultrasound solution for pediatric assessment provides a gentler approach to imaging children

Philips first of its kind ultrasound solution for pediatric assessment provides a gentler approach to imaging children

May 6, 2020 

Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the , the latest addition for its Philips Ultrasound System (. The new ultrasound solution provides clinicians with exceptionally detailed images and the performance they need to make a definitive diagnosis for pediatric patients, reducing the need for additional diagnostic imaging steps, such as X-ray imaging.

The new ultrasound solution from Philips is designed specifically for pediatric clinical use. It combines dedicated transducers, enhanced processing, and software tools that are optimized for the pediatric diagnostic workflow to help improve the experience of both young patients and staff. Children are more radiosensitive than adults, and efforts should be made to minimize risk by reducing unnecessary exposure to radiation [1]. So, a more gentle form of medical imaging is recommended when there is a clear indication for use.

“The new pediatric assessment solution on the EPIQ Elite system has elevated our ultrasound practice at Phoenix Children’s,” said Dr. Luis Goncalves, Pediatric Radiologist at Phoenix Children’s Hospital. “In particular, the solution’s new transducer offers exceptional clinical performance and versatility across many pediatric applications. For example, the intracranial detail we see in the neonatal head is truly exceptional.”

Pediatric patients come in all shapes and sizes. From the tiniest premature newborn baby to adult-sized pediatric patients, Philips offers a complete imaging solution to elevate diagnostic confidence in even the most challenging cases. The Philips ultimate ultrasound solution for pediatric assessment includes a new pediatric transducer, offering a 30% greater penetration [2] for more detailed images, and has a tailored pediatric workflow to help clinicians diagnose pediatric patients more quickly.

“Diagnostic confidence is vital for any clinician, especially when diagnosing the most sensitive patients,” said Jeff Cohen, Vice President, and General Manager General Imaging Ultrasound at Philips. “Philips ultimate ultrasound solutions provide the right level of image detail and context that clinicians need to make a precise diagnosis.”

The Philips ultimate ultrasound solution for pediatric assessment is cleared for pediatric clinical use. It extends Philips’ portfolio of dedicated solutions on the Philips Ultrasound System (EPIQ Elite) tailored to the needs of particular medical specialties. Ultrasound solutions for clinical use from Philips are available for the assessment of , , , , and now .

Availability

Philips ultimate ultrasound solution for pediatric assessment and the Ultrasound System (EPIQ Elite) update are available globally [3].

[1] /radiation-emitting-products/medical-imaging/pediatric-x-ray-imaging

[2] The new mC12-3 pediatric transducer offers 30% greater penetration in comparison to the previous generation

[3] Worldwide availability, excluding China and few other countries

For further information, please contact:

Hans Driessen

Philips Global Press Office

Tel.:

E-mail:    

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries. News about Philips can be found at .



 

Attachment

EN
06/05/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

MDIC appoints Philips Chief Medical Officer Carla Goulart Peron as new...

MDIC appoints Philips Chief Medical Officer Carla Goulart Peron as new board member April 2, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Carla Goulart Peron, MD, Chief Medical Officer at Philips, has been appointed to the of the Medical Device Innovation Consortium (). Founded in 2012, MDIC is a unique public-private partnership that brings stakeholders across the medical device spectrum together with the US Food and Drug Administration () and other agency partners to help ensure patient access to medical device inn...

 PRESS RELEASE

FDA clears Philips AI solution that provides real-time guidance during...

FDA clears Philips AI solution that provides real-time guidance during complex minimally invasive heart valve repair March 26, 2026 Philips DeviceGuide uses AI to track and visualize mitral valve repair devices [1] in real time during minimally invasive procedures, supporting treatment [2]DeviceGuide integrates with Philips Azurion image-guided therapy platform that combines imaging, real-time data and intelligent software within a unified workflow to support more consistent, efficient and confidently guided minimally invasive procedures Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA...

 PRESS RELEASE

Philips launches IntraSight Plus to simplify coronary interventions an...

Philips launches IntraSight Plus to simplify coronary interventions and advance precision care March 25, 2026 Intuitive interventional cardiology platform combines the most comprehensive set of diagnostic and treatment planning tools to help support confident decisions and improved patient careWith FDA clearance and CE marking, IntraSight Plus streamlines the workflow efficiency of minimally invasive coronary procedures and can enable system operation time savings up to 47% in both the USA and Europe Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technolog...

 PRESS RELEASE

Philips remains No. 1 in Medtech at European Patent Office and the lar...

Philips remains No. 1 in Medtech at European Patent Office and the largest Dutch patent applicant March 24, 2026 Philips ranks No. 1 among medical technology companies in the European Patent Office Technology Dashboard 2025, filing 1,289 patent applications with the EPO in 2025.Philips’ platform-based solutions integrate hardware, software, data and AI to address clinical, operational and everyday health challenges.Philips’ innovation improved the lives of 2 billion people in 2025, with the goal of improving 2.5 billion lives per year by 2030, including 400 million people in medically unde...

 PRESS RELEASE

Philips convenes the Annual General Meeting of Shareholders 2026

Philips convenes the Annual General Meeting of Shareholders 2026 March 23, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has convened the Annual General Meeting of Shareholders (AGM) 2026 and published the agenda with explanatory notes. As previously announced, the agenda includes: Proposal to appoint John DeFord (American, 1962) as new member of the Supervisory Board, with effect from May 8, 2026.Proposals to re-appoint Paul Stoffels (Belgian, 1962), Herna Verhagen (Dutch, 1966) and Sanjay Poonen (American, 1969) as m...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch